1.Study on quality indicators for concentration process of supernatant obtained in first ethanol precipitation in production of Danshen injection.
Han ZHANG ; Anyi YAN ; Xingchu GONG ; Haibing QU
China Journal of Chinese Materia Medica 2011;36(11):1436-1440
According to the effect of second ethanol precipitation (SEP) in the production of Danshen injection, the indicators for controlling the quality of a concentration process of the supernatant obtained in the first ethanol precipitation (FEP) were investigated. The concentrated supernatants of FEP with different constituents were prepared and treated with the same amount of ethanol. The parameters which affect phenolic compound retention ratios in SEP supernatant were found using a stepwise regression method. Phenolic compound contents in SEP supernatant were mainly affected by pH and caffeic acid content of the concentrated supernatant of FEP. Caffeic acid content and pH should be set as quality indicators and strictly controlled in concentrating the supernatant of FEP.
Caffeic Acids
;
chemistry
;
Chemical Precipitation
;
Ethanol
;
chemistry
;
Hydrogen-Ion Concentration
;
Injections
;
Plant Extracts
;
chemistry
;
Quality Control
;
Regression Analysis
;
Salvia miltiorrhiza
;
chemistry
2.Recombinant goat pox virus expressing PPRV H protein.
Weiye CHEN ; Linmao QU ; Sen HU ; Qianqian HU ; Qian ZHANG ; Haibing ZHI ; Kehe HUANG ; Zhigao BU
Chinese Journal of Biotechnology 2009;25(4):496-502
The purpose of the study is to construct recombinant goat pox virus (GPV) expressing Peste des petits ruminants virus (PPRV) H protein, and to evaluate the immunization effect. Recombinant GPV containing PPRV H gene (rGPV-PPRV-H) was selected and purified by gpt and eGFP utilizing plaque purification, and the final selected recombinant GPV was proved to be purified by PCR. Immunofluorescence and Western blotting showed that the recombinant virus could express H protein of PPRV while infecting lamb testis cells. Six goats were immunized with 2 x 10(6) PFU rGPV-PPRV-H through intradermal injection, and were immunized for the second time at 28 days with the same dose recombinant virus after first immunization. Serum was collected after immunization, and was analyzed for the neutralization antibodies. 21 days after first immunization, the neutralization antibodies of GPV were 40, 80, > or = 80, > or = 80, 40, > or = 80 in turn, and neutralization antibodies of PPRV were 80, 80, 80, 80, 40, 40, 10 in turn; 14 days after second immunization, the neutralization antibodies of GPV were all > or = 80, and the neutralization antibodies of PPRV were > 80, 80, > 80, 80, 80 and 40 in turn. This study established a foundation for the industrialization of the PPRV recombinant GPV vaccine.
Animals
;
Capripoxvirus
;
genetics
;
immunology
;
Goat Diseases
;
immunology
;
prevention & control
;
virology
;
Goats
;
Hemagglutinins, Viral
;
genetics
;
immunology
;
metabolism
;
Peste-des-Petits-Ruminants
;
immunology
;
prevention & control
;
Peste-des-petits-ruminants virus
;
genetics
;
immunology
;
Recombinant Proteins
;
genetics
;
immunology
;
metabolism
;
Vaccines, Combined
;
immunology
;
Vaccines, Synthetic
;
immunology
;
Viral Vaccines
;
immunology